ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 85230 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 85230; 2) Community: the network communities that were significantly associated with the response to NSC 85230; 3) Molecule: the relationships between components within communities and NSC 85230; 4) MDR: the compounds that were significantly associated with the NSC 85230.

NSC Compound Enrichment Correlation
NSC 328410 Camptothecin Derivative 0.00803384002766641 0.71074051
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00803384002766641 0.45585139
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00803384002766641 0.40435398
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.00803384002766641 0.66709592
NSC 658259 Null 0.00803384002766641 0.13510039
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.00803384002766641 0.11101325
NSC 681641 Camptothecin Derivative 0.00803384002766641 0.74470739
NSC 683556 Camptothecin Derivative 0.00803384002766641 0.7594578
NSC 700363 Liposomal Annamycin 0.00803384002766641 0.7319941
NSC 726365 Null 0.00803384002766641 0.081166424
Total:67  Current:16    [First] [Prev] [Next] [Last]